[Factor XIII and wound healing].
In addition to those wounds with increasing fragility of capillaries during impaired healing, there are especially long lasting diabetic wounds or calf ulcerations due to chronic venous insufficiency or postthrombotic syndrome that show a failure of endothelial barrier function with an increased permeability as an important part of its pathophysiological situation. The possibility of controlling this increased permeability is of great therapeutical interest and may give distinct benefit for wound healing. In the close past, clinical as well as experimental studies revealed the plasma transglutaminase (factor XIIIa) as potential new strategy in treatment of increased vascular permeability.
Wozniak
G
G
Klinik für Gefässchirurgie, Knappschaftskrankenhaus Bottrop. gernold.wozniak@kk-bottrop.de
Noll
Th
T
D005176:Factor XIII / Q000502:physiology*; D006801:Humans; D014456:Ulcer / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D014945:Wound Healing / Q000502:physiology*
D005176:Factor XIII